Accessibility Menu
Kyowa Kirin logo

Kyowa Kirin(OTC) KYKOF

Market Cap$8.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+207%
5 Year-42%
1 Year-5%
1 Month+10%
$15.80
+0.00%
+0.00Today
Kyowa Kirin last closing stock price
MetricPriceDate
Last closeUSD 15.802026-09-02
Kyowa Kirin stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.53%USD 14.432026-08-19
1 month+9.53%USD 14.432026-08-03
3 month+11.19%USD 14.212026-06-01
Year to date+2.55%USD 15.412025-12-31
1 year-5.14%USD 16.662025-07-31
3 year-6.94%USD 16.982023-08-31
5 year-41.79%USD 27.142021-09-01
Since inception+207.47%USD 5.142003-07-31

Kyowa Kirin Financials at a Glance

Market Cap

$8.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥529.93B

Net Income (TTM)

¥81.34B

EPS (TTM)

$1.01

P/E Ratio

15.69

Dividend

$0.42

Beta (Volatility)

0.05 (Low)

Price

$15.80

Volume

100

Open

$15.80

Previous Close

$15.80

Daily Range

$15.80 - $15.80

52-Week Range

$12.42 - $18.00

Estimated Earnings Date

Oct 29, 2026

KYKOF News

m&A

Why Orchard Therapeutics Stock Is Soaring Today

George Budwell, PhDOct 5, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kyowa Kirin

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,161

CEO

Abdul Mullick, PhD

Website

www.kyowa-kirin.co.jp

Headquarters

Tokyo, TY 100-0004, JP

KYKOF Financials

Key Financial Metrics (TTM)

Gross Margin

73.91%

Operating Margin

24.38%

Net Income Margin

15.35%

Return on Equity

9.17%

Return on Capital

11.12%

Return on Assets

7.19%

Earnings Yield

6.37%

Dividend Yield

2.65%

Payout Ratio

39.90%

Stock Overview

Market Cap

$8.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

523.59M

Volume

100

Avg. Volume

98.359

Financials (TTM)

Gross Profit

¥392.76B

Operating Income

¥119.54B

EBITDA

¥158.41B

Operating Cash Flow

¥142.14B

Capital Expenditure

-¥38.80B

Free Cash Flow

¥103.34B

Cash & ST Invst.

¥263.17B

Total Debt

¥22.04B

Kyowa Kirin Performance Analysis

Kyowa Kirin annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 3,028,800,292-5.5%
20232023-12-31JPY 3,145,038,2043.8%
20242024-12-31JPY 3,271,119,9434.0%
20252025-12-31JPY 3,321,040,1671.5%
Kyowa Kirin sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.3%
Q42025-12-3121.3%
Q12026-03-31-18.4%
Q22026-06-3020.9%
Kyowa Kirin annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 0.76-14.5%
20232023-12-31JPY 1.0741.7%
20242024-12-31JPY 0.75-30.5%
20252025-12-31JPY 0.8614.7%
Kyowa Kirin sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3062.6%
Q42025-12-31107.5%
Q12026-03-31-65.8%
Q22026-06-3058.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

¥144.11B

+14.4%

Gross Profit

¥105.27B

+18.7%

Gross Margin

73.05%

N/A

Market Cap

$8.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.60M

N/A

Employees

5,161

N/A

Net Income

¥18.45B

+81.7%

EBITDA

¥50.54B

+183.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

¥263.17B

+11.4%

Total Debt

¥22.04B

+13713.1%

Accounts Receivable

¥152.19B

-4.1%

Inventory

¥64.22B

-11.9%

Long Term Debt

¥22.04B

N/A

Short Term Debt

¥0.00

N/A

Return on Assets

7.19%

N/A

Return on Invested Capital

13.62%

N/A

Free Cash Flow

¥18.60B

-21.6%

Operating Cash Flow

¥24.82B

-23.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIFLFGrifols, S.A.
$11.76+0.00%
ESAIYEisai Co., Ltd.
$7.67+3.16%
ESALFEisai Co., Ltd.
$31.00+0.00%
SSMXYSysmex Corporation
$12.46+3.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About KYKOF

What is the current price of Kyowa Kirin?

Kyowa Kirin is trading at $15.80 per share.

What is the 52-week range for Kyowa Kirin?

Over the past 52 weeks, Kyowa Kirin has traded between $12.42 and $18.00.

How much debt does Kyowa Kirin have?

As of the most recent reporting period, Kyowa Kirin reported total debt of ¥136.61M.

How much cash does Kyowa Kirin have on hand?

Kyowa Kirin reported ¥1.63B in cash and cash equivalents in its most recent financial results.

What is Kyowa Kirin’s dividend yield?

Kyowa Kirin currently has a dividend yield of 2.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services